Literature DB >> 26617776

Ectopic expressed miR-203 contributes to chronic obstructive pulmonary disease via targeting TAK1 and PIK3CA.

Liang Shi1, Qinghong Xin2, Ruonan Chai3, Lei Liu3, Zhuang Ma3.   

Abstract

MiRNA is a group of powerful short non-coding RNAs that suppress the expression of protein coding genes by targeting to the 3'UTRs of mRNAs. Some researchers have detected the miRNAs expression profile in tissue and blood samples of chronic obstructive pulmonary disease (COPD) patients recently. Several disturbed miRNAs were found to be related to COPD; however, the mechanisms were still well understood. In this study, we first detected the expression of 11 candidate miRNAs in the lung samples of COPD patients, non-COPD smokers and non-smock controls. We found that the expression of miR-181a, miR-203, miR-338, miR-1 and miR-199a was altered compared with control. Subsequently, we detected these five miRNAs expression in the blood samples of the participants. A significant higher expression of miR-203 was found in the blood samples of smokers and COPD patients. Predicted by bioinformatics tools and confirmed by luciferase assay and western blot, we demonstrated that TAK1 and PIK3CA are two direct targets of miR-203. Furthermore, we detected a lower p-IκBα and p-p65 level in the bronchial/tracheal epithelial cells from COPD patients compared with the cells from healthy controls, when stimulated by LPS. The concentration of TNF-α and IL-6 in the medium from bronchial/tracheal epithelial cells from COPD patients is also lower. Meanwhile, the miR-203 level was down-regulated significantly in the control cells, but non-significant change in the cells from COPD patients. miR-203 represses NF-κB signaling via targeting TAK1 and PI3KCA and miR-203 overexpression may contribute to the COPD initiation.

Entities:  

Keywords:  MicroRNA; NF-κB; chronic obstructive pulmonary disease

Mesh:

Substances:

Year:  2015        PMID: 26617776      PMCID: PMC4637591     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  17 in total

1.  Comparison of the structural and inflammatory features of COPD and asthma. Giles F. Filley Lecture.

Authors:  P K Jeffery
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

2.  Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team.

Authors:  J P Nuorti; J C Butler; M M Farley; L H Harrison; A McGeer; M S Kolczak; R F Breiman
Journal:  N Engl J Med       Date:  2000-03-09       Impact factor: 91.245

Review 3.  The airway epithelium: more than just a structural barrier.

Authors:  Anthony Tam; Samuel Wadsworth; Delbert Dorscheid; S F Paul Man; Don D Sin
Journal:  Ther Adv Respir Dis       Date:  2011-03-03       Impact factor: 4.031

Review 4.  [MicroRNAs--new biomarkers of respiratory tract diseases].

Authors:  Maciej Kupczyk; Piotr Kuna
Journal:  Pneumonol Alergol Pol       Date:  2014

5.  The T-helper cell type 1 immune response to gram-negative bacterial infections is impaired in COPD.

Authors:  Jürgen Knobloch; Katharina Schild; David Jungck; Katja Urban; Katja Müller; Elke K H Schweda; Jan Rupp; Andrea Koch
Journal:  Am J Respir Crit Care Med       Date:  2010-08-13       Impact factor: 21.405

Review 6.  Systemic manifestations and comorbidities of COPD.

Authors:  P J Barnes; B R Celli
Journal:  Eur Respir J       Date:  2009-05       Impact factor: 16.671

7.  MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD.

Authors:  Sonia Molina-Pinelo; M Dolores Pastor; Rocío Suarez; Beatriz Romero-Romero; Miriam González De la Peña; Ana Salinas; Rocío García-Carbonero; María José De Miguel; Francisco Rodríguez-Panadero; Amancio Carnero; Luis Paz-Ares
Journal:  Eur Respir J       Date:  2014-04-17       Impact factor: 16.671

8.  Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation.

Authors:  Joanna Stanczyk; Caroline Ospelt; Emmanuel Karouzakis; Andrew Filer; Karim Raza; Christoph Kolling; Renate Gay; Christopher D Buckley; Paul P Tak; Steffen Gay; Diego Kyburz
Journal:  Arthritis Rheum       Date:  2011-02

9.  Epigenetic mechanisms in respiratory muscle dysfunction of patients with chronic obstructive pulmonary disease.

Authors:  Ester Puig-Vilanova; Rafael Aguiló; Alberto Rodríguez-Fuster; Juana Martínez-Llorens; Joaquim Gea; Esther Barreiro
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

Review 10.  MicroRNAs and respiratory diseases.

Authors:  Hitasha Rupani; Tilman Sanchez-Elsner; Peter Howarth
Journal:  Eur Respir J       Date:  2012-07-12       Impact factor: 16.671

View more
  11 in total

Review 1.  MicroRNA mediated regulation of immunity against gram-negative bacteria.

Authors:  Jonathon Keck; Rishein Gupta; Lane K Christenson; Bernard P Arulanandam
Journal:  Int Rev Immunol       Date:  2017-08-11       Impact factor: 5.311

2.  MicroRNAs as the Potential Regulators of SARS-CoV-2 Infection and Modifiers of the COVID-19 Clinical Features.

Authors:  A N Kucher; Iu A Koroleva; A A Zarubin; M S Nazarenko
Journal:  Mol Biol       Date:  2022-02-12       Impact factor: 1.540

Review 3.  Noncoding RNA Profiles in Tobacco- and Alcohol-Associated Diseases.

Authors:  Nayra Soares do Amaral; Natalia Cruz E Melo; Beatriz de Melo Maia; Rafael Malagoli Rocha
Journal:  Genes (Basel)       Date:  2016-12-23       Impact factor: 4.096

4.  Circulating miR-146a/b correlates with inflammatory cytokines in COPD and could predict the risk of acute exacerbation COPD.

Authors:  Bei-Bei Chen; Zhen-Hua Li; Shan Gao
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.817

Review 5.  MicroRNAs as Potential Regulators of Immune Response Networks in Asthma and Chronic Obstructive Pulmonary Disease.

Authors:  José A Cañas; José M Rodrigo-Muñoz; Beatriz Sastre; Marta Gil-Martinez; Natalia Redondo; Victoria Del Pozo
Journal:  Front Immunol       Date:  2021-01-08       Impact factor: 7.561

Review 6.  Epigenetic Mechanisms in Parenchymal Lung Diseases: Bystanders or Therapeutic Targets?

Authors:  Edibe Avci; Pouya Sarvari; Rajkumar Savai; Werner Seeger; Soni S Pullamsetti
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923

7.  Evaluation of selected IL6/STAT3 pathway molecules and miRNA expression in chronic obstructive pulmonary disease.

Authors:  J M Kiszałkiewicz; S Majewski; W J Piotrowski; P Górski; D Pastuszak-Lewandoska; M Migdalska-Sęk; E Brzeziańska-Lasota
Journal:  Sci Rep       Date:  2021-11-23       Impact factor: 4.379

Review 8.  Molecular Background of miRNA Role in Asthma and COPD: An Updated Insight.

Authors:  Izabela Szymczak; Joanna Wieczfinska; Rafal Pawliczak
Journal:  Biomed Res Int       Date:  2016-06-08       Impact factor: 3.411

Review 9.  Chronic obstructive pulmonary disease: MicroRNAs and exosomes as new diagnostic and therapeutic biomarkers.

Authors:  Jafar Salimian; Hamed Mirzaei; Abdullah Moridikia; Asghar Beigi Harchegani; Amirhossein Sahebkar; Hossein Salehi
Journal:  J Res Med Sci       Date:  2018-03-27       Impact factor: 1.852

10.  Dysregulated circulating microRNA-126 in chronic obstructive pulmonary disease: linkage with acute exacerbation risk, severity degree, and inflammatory cytokines.

Authors:  Congying Wang; Dong Feng; Shanfeng Dong; Ruilian He; Bosheng Fan
Journal:  J Clin Lab Anal       Date:  2022-01-21       Impact factor: 3.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.